Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
XRAY 
Dentsply Sirona Inc (XRAY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: XRAY (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
17 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $16.29
1 Year Target Price $16.29
| 2 | Strong Buy |
| 2 | Buy |
| 13 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -37.3% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.52B USD | Price to earnings Ratio - | 1Y Target Price 16.29 |
Price to earnings Ratio - | 1Y Target Price 16.29 | ||
Volume (30-day avg) 17 | Beta 0.96 | 52 Weeks Range 11.69 - 23.84 | Updated Date 10/17/2025 |
52 Weeks Range 11.69 - 23.84 | Updated Date 10/17/2025 | ||
Dividends yield (FY) 5.07% | Basic EPS (TTM) -4.68 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -25.85% | Operating Margin (TTM) 11.65% |
Management Effectiveness
Return on Assets (TTM) 2.72% | Return on Equity (TTM) -37.73% |
Valuation
Trailing PE - | Forward PE 6.57 | Enterprise Value 4720310838 | Price to Sales(TTM) 0.69 |
Enterprise Value 4720310838 | Price to Sales(TTM) 0.69 | ||
Enterprise Value to Revenue 1.29 | Enterprise Value to EBITDA 25.4 | Shares Outstanding 199483861 | Shares Floating 185541934 |
Shares Outstanding 199483861 | Shares Floating 185541934 | ||
Percent Insiders 0.39 | Percent Institutions 104.22 |
Upturn AI SWOT
Dentsply Sirona Inc
Company Overview
History and Background
Dentsply Sirona, Inc. was formed in 2016 through the merger of Dentsply International and Sirona Dental Systems. Dentsply was founded in 1899 and Sirona in 1877. The merger created the world's largest manufacturer of professional dental products and technologies.
Core Business Areas
- Consumables: Develops, manufactures and markets a broad range of dental consumable products, including restorative materials, endodontic instruments, rotary files, cements, impression materials, preventives, anesthetics, prophylaxis products, dental implants, and small equipment.
- Technologies & Equipment: Offers dental equipment and technology such as CAD/CAM systems (CEREC), imaging systems (CBCT, intraoral, extraoral), treatment centers, and instruments.
Leadership and Structure
Simon Campion is the Chief Executive Officer. The company has a Board of Directors that oversees corporate governance. The organizational structure is divided into business units based on product categories and geographical regions.
Top Products and Market Share
Key Offerings
- CEREC (CAD/CAM System): CEREC is a chairside CAD/CAM system for creating dental restorations like crowns, inlays, and onlays. It is a market leader in chairside CAD/CAM. Competitors include Planmeca, 3Shape, and Align Technology. Market share difficult to ascertain precisely, but considered one of the largest players in this area.
- Axeos (Imaging System): Axeos is a 3D imaging system that offers CBCT (cone beam computed tomography) scans. Competitors include Carestream Dental, Planmeca, and Vatech. Market Share data is not readily available.
- Endodontic Solutions: A range of products for root canal procedures, including files, irrigants, and obturation materials. They compete with companies such as Coltene Whaledent and Kerr Dental. Market Share data is not readily available.
Market Dynamics
Industry Overview
The dental industry is growing due to aging populations, increased awareness of oral hygiene, and technological advancements. It is competitive and fragmented.
Positioning
Dentsply Sirona is positioned as a leading provider of comprehensive dental solutions, with a strong brand reputation and global presence. It benefits from a large product portfolio and a focus on innovation.
Total Addressable Market (TAM)
The global dental market is estimated to be valued at over $40 billion and is expected to grow at a compound annual growth rate (CAGR) of approximately 5-7%. Dentsply Sirona aims to capture a significant portion of this TAM through product innovation and market expansion.
Upturn SWOT Analysis
Strengths
- Global Brand Recognition
- Extensive Product Portfolio
- Strong R&D Capabilities
- Established Distribution Network
- Leading Market Position
Weaknesses
- High Debt Levels
- Complex Integration Challenges (from Merger)
- Product Recalls (Historically)
- Dependence on Developed Markets
Opportunities
- Expanding into Emerging Markets
- Developing Innovative Digital Solutions
- Acquiring Complementary Businesses
- Increasing Adoption of Dental Implants
- Growth in Teledentistry
Threats
- Intense Competition
- Changing Regulatory Landscape
- Economic Downturns
- Pricing Pressure
- Emergence of Low-Cost Alternatives
Competitors and Market Share
Key Competitors
- Straumann (SAUHF)
- Envista Holdings (NVST)
- Align Technology (ALGN)
- Danaher Corporation (DHR)
Competitive Landscape
Dentsply Sirona is a large player with a comprehensive portfolio, but faces strong competition from specialized companies in specific product categories. Its competitive advantages include its brand recognition, global distribution network, and R&D capabilities. Weaknesses include high debt and integration challenges.
Major Acquisitions
Propel Orthodontics
- Year: 2019
- Acquisition Price (USD millions): 131
- Strategic Rationale: Expanded Dentsply Sirona's offerings in the orthodontic market and integrated innovative technology to accelerate tooth movement.
Growth Trajectory and Initiatives
Historical Growth: Growth has been inconsistent due to economic factors, integration challenges, and product recalls. Recent years have shown moderate revenue growth.
Future Projections: Analysts project moderate revenue growth driven by new product launches, expansion into emerging markets, and increasing adoption of digital solutions. Growth rates are expected in the mid-single digits.
Recent Initiatives: Dentsply Sirona is focused on simplifying its portfolio, improving operational efficiency, and investing in innovation. They are also pursuing strategic acquisitions in high-growth areas.
Summary
Dentsply Sirona is a major player in the dental industry with a broad portfolio, but faces challenges. Its strong brand, global presence, and R&D are strengths, but high debt and integration issues are weaknesses. Growth opportunities lie in emerging markets and digital solutions. Competition and economic factors pose ongoing threats.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market data and analyst estimates are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Dentsply Sirona Inc
Exchange NASDAQ | Headquaters Charlotte, NC, United States | ||
IPO Launch date 1987-08-12 | President, CEO & Director Mr. Daniel T. Scavilla | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 14000 | Website https://www.dentsplysirona.com |
Full time employees 14000 | Website https://www.dentsplysirona.com | ||
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers intermittent urinary catheters under the LoFric brand and irrigation systems under the Navina brand. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.